EP Patent

EP1454992B1 — Anaplastic lymphoma kinase assay, reagents and compositions thereof

Assigned to Istituto Nazionale per lo Studio e la Cura die Tumori · Expires 2006-05-31 · 20y expired

What this patent protects

Disclosed are methods for detecting ALK tyrosine kinase activity and for the identification of compounds that modulate ALK activity, peptide substrates, reagents and compositions thereof.

USPTO Abstract

Disclosed are methods for detecting ALK tyrosine kinase activity and for the identification of compounds that modulate ALK activity, peptide substrates, reagents and compositions thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP1454992B1
Jurisdiction
EP
Classification
—
Expires
2006-05-31
Drug substance claim
No
Drug product claim
No
Assignee
Istituto Nazionale per lo Studio e la Cura die Tumori
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.